Get more replies from employers
Send a job-specific resume in minutes.
Convatec in the Rhymney area of Wales is seeking an entry-level Production Operator to produce wound care intermediates and operate process equipment. The role involves raw material handling, equipment operation, batch documentation, and supporting CI activities.
Training will be provided on GDP, GMP, and safety procedures. Role requires basic English and mathematics skills, adherence to procedures, and a proactive attitude to learn the Rhymney production processes.
Manufacturing Production manages or assists with various production activities (e.g., assembly, material forming/shaping, processing, treating, or packaging, etc.) including:
An entry-level position typically requiring little to no prior knowledge or experience.
Production of wound care intermediates through operation of process equipment
Role involves shift working (8 hour rotating double day pattern)
Role based in combination of Clean rooms and production areas.
Convatec provides equal employment opportunities for all current employees and applicants for employment. This policy means that no one will be discriminated against because of race, religion, creed, color, national origin, nationality, citizenship, ancestry, sex, age, marital status, physical or mental disability, affectional or sexual orientation, gender identity, military or veteran status, genetic predisposing characteristics or any other basis prohibited by law.
If you are an active employee at Convatec, please do not apply here. Go to the Career Worklet on your Workday home page and View "Convatec Internal Career Site - Find Jobs". Thank you!
Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With over 10,000 colleagues, we provide products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention, treatment for hard to heal wounds, at-risk skin and ulcerated tissue to supporting debilitating conditions, improved patient outcomes and reduced care costs. Convatec's revenues in 2025 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit: http://www.convatecgroup.com.